Optimizing Sleep in Elderly Patients with Insomnia

Introduction to Insomnia Management

• The American Academy of Sleep Medicine recommends optimizing existing medications before adding new agents for insomnia treatment, such as increasing mirtazapine to 30 mg at bedtime, which is more effective for sleep and guideline-recommended for insomnia 1, 2, 3

Medication Optimization

• Increasing mirtazapine from 15 mg to 30 mg at bedtime is recommended as it promotes appetite, does not suppress REM sleep, and addresses anxiety, with the American Academy of Sleep Medicine providing a guideline recommendation for its use in insomnia treatment 1, 2, 3
• The American Academy of Sleep Medicine provides a WEAK recommendation for zolpidem based on moderate-quality evidence, with a recommended dose of 5 mg at bedtime for elderly patients with sleep onset and maintenance insomnia 5

Non-Pharmacologic Interventions

• Cognitive Behavioral Therapy for Insomnia (CBT-I) should be strongly pursued as an adjunct to medication adjustment, including stimulus control, sleep restriction, and progressive muscle relaxation, to address underlying sleep dysfunction and facilitate eventual medication tapering 1, 2, 7, 3

Safety Considerations

• The American Academy of Sleep Medicine recommends against the use of benzodiazepines in elderly patients due to high risk of dependence, tolerance, and withdrawal, as well as antihistamines due to serious anticholinergic side effects 4, 5, 7
• Screening for primary sleep disorders, such as sleep apnea, is crucial as these require specific treatment beyond hypnotics and can explain medication failure 1, 2, 7